Related Experiment Video
Updated: Apr 12, 2026

09:41
Reconstitution Of β-catenin Degradation In Xenopus Egg Extract
Published on: June 17, 2014
12.6K
Expression, purification and auto-activation of cathepsin E from insect cells
Tajana Z Železnik, Vida Puizdar, Iztok Dolenc1
1Jozef Stefan Institute, Department of Biochemistry and Molecular and Structural Biology, Jamova 39, SI-1000 Ljubljana, Slovenia. iztok.dolenc@ijs.si.
Protein and Peptide Letters
|May 12, 2015
Summary
Researchers developed a new method to produce and purify human Cathepsin E, an enzyme linked to pancreatic cancer. This high-yield purification protocol will aid future studies on the enzyme and potential therapies.
Area of Science:
- Biochemistry
- Molecular Biology
- Enzymology
Background:
- Cathepsin E is an aspartic protease in the pepsin family.
- It shares similarities with Cathepsin D but has distinct tissue and cellular localization.
- Elevated Cathepsin E levels are associated with various tumors, notably pancreatic ductal adenocarcinoma.
Purpose of the Study:
- To establish a novel, high-yield protocol for purifying recombinant human Cathepsin E.
- To facilitate further research into Cathepsin E's structure-function relationship.
- To support the development of targeted therapeutic strategies.
Main Methods:
- Utilized the baculovirus expression system for recombinant protein production in Sf9 insect cells.
- Purified the inactive zymogen (procathepsin E) via ion-exchange, size exclusion, pepstatin-affinity, and heparin-affinity chromatography.
- Activated the purified zymogen at acidic pH to obtain active Cathepsin E.
Main Results:
- Achieved high-yield purification of recombinant human procathepsin E.
- Successfully activated the zymogen to yield active Cathepsin E.
- Confirmed that the purified enzyme's activity, stability, and molecular weight match native Cathepsin E.
Conclusions:
- A robust and efficient protocol for recombinant human Cathepsin E purification has been developed.
- This method enables the production of sufficient quantities of active enzyme for detailed investigation.
- The enhanced availability of Cathepsin E will advance understanding and therapeutic development for associated diseases.

